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The most prominent polymer for 
many biomedical applications is pres-
ently poly(ethylene glycol) (PEG), which 
can ameliorate the stability of the pep-
tide structure regarding harsh environ-
mental conditions.[3,5,6] However, other 
water-soluble polymers that offer multiple 
conjugation sites through multiple side 
chain functionalities can be interesting 
alternatives to PEG, which only offers α- 
or ω-end functionalization. One of those 
polymers are poly(2-alkyl-2-oxazoline)s 
(POX), which have already been explored 
for peptide–polymer conjugation by sev-
eral researchers.[7,8] For example, Luxen-
hofer et al. attached a cyclic RGD peptide 
using copper mediated click-chemistry[9,10] 
and Schmitz et al.[11] attached thioester 
functional peptides to a multifunctional 
cysteine POX copolymer. POX is gener-
ally synthesized via cationic ring opening 
polymerization (CROP) and through a vast 
variety of monomers, different functional 
side chains can be easily incorporated into the polymer using 
appropriate copoly merization schemes.[12]
Another interesting functionality for such polymers is the elec-
trophilic azlactone, which is basically a “masked” amino acid[13] 
and readily reacts with amines, thiols, and hydroxyls[14] without 
additional activation and the formation of any by-products. Based 
on these advantages, it could be a pro mising alternative to the 
commonly used N-hydroxysuccinimide active esters used in 
many conjugation reactions.[15–17] Azlactones have already been 
used in peptide ligation as they offer the opportunity to integrate 
chiral amino acids through stereoselective alkylation with sub-
sequent ligation.[18] In polymer chemistry, 2-vinyl-4,4-dimethyl 
azlactone (VDMA) has been so far mainly polymerized by free 
radical polymerization using methacrylic acid as co-monomer, by 
atom transfer radical polymerization[19] to receive pure PVDMA 
or by reversible addition–fragmentation chain transfer (RAFT) 
polymerization with N-isopropyl acrylamide and N,N-dimeth-
ylacrylamide.[20] Surface anchored PVDMA brushes have also 
been used for protein immobilization, for example, RNase A, 
where the activity of the immobilized protein was close to the free 
enzyme.[21] Vinyl-functional azlactones were also applied for mac-
romonomer functionalization, for example, amino group bearing 
gelatin was functionalized with 2-isopropenyl-4,4-dimethylazlac-
tone at room temperature making it available for the formation 
of hydrogels via radical cross-linking, which was used to support 
in vitro cell growth.[22] Copolymers of poly(ethylene glycol methyl 
ether methacrylate-ran-vinyl azlactone-ran-glycidyl methacrylate) 
The physical and chemical stability of peptides for biomedical applications 
can be greatly enhanced through the conjugation of polymers. A well-known 
but rather underemployed selective coupling functionality is the azlactone 
group, which readily reacts with a number of different nucleophiles without 
the need for activation and the formation of any by-products. For example, 
azlactone functional polymers are used to react with peptides and proteins, 
rich in amino and thiol groups, to form polymeric beads for affinity-based 
column chromatography. So far, side chain functional azlactone polymers 
have been mainly synthesized by radical polymerization using 2-vinyl-
4,4-dimethyl azlactone together with different acrylate monomers. Here, a 
new azlactone precursor equipped with a functional thiol is presented, which 
can be attached to any vinyl functional polymer by thiol–ene chemistry. Sub-
sequently, the formation of the reactive azlactone ring can be performed in 
situ at high conversion rate without the need for illumination. This approach 
is tested on an azlactone side functional poly(2-oxazoline) by coupling amine 
containing molecules including a model peptide and is proven via 1H NMR 
spectroscopy, IR spectroscopy, as well as HPLC measurements.
1. Introduction
Covalently linked peptide–polymer conjugates have been exten-
sively researched for many biomedical applications as they can 
be used, for example, for drug delivery, for the stabilization of 
protein therapeutics or in tissue engineering and biosensing 
applications.[1–5] Besides selecting the appropriate peptide or 
protein, the polymer used for conjugation should be carefully 
chosen with regard to its physical and chemical properties as 
well as its biocompatibility and degradability.
© 2019 The Authors. Published by WILEY-VCH Verlag GmbH & Co. 
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have been used as thin film coatings on silicon and polycarbonate 
substrates and tested with different peptides with thiol, amino, 
and cysteine N-terminus. It was found that the thioester bound 
peptides were not stable under cell culture conditions and would 
undergo hydrolysis. The coupling efficiency of peptides with 
primary amines at the N-terminus was rather low, but peptides 
with a cysteine at the N-terminus showed greater immobilization 
potential, which was explained by a rearrangement mechanism to 
the stable amide similar to the one observed during native chem-
ical ligation (NCL).[23] It was furthermore shown by Ho et al. that 
it is possible to attach azlactone copolymers as well as heterobi-
functional azlactone linkers to a more complex protein, lysozyme, 
with higher efficiency in DMSO than in aqueous buffer,[17,20] 
which can be explained by the fact that there is a competition 
between the amide bond formation and the undesired azlactone 
hydrolysis to carboxylic acids through the excess of water mole-
cules.[16] A range of water-soluble copolymers of VDMA with ani-
onic, polar uncharged, and zwitterionic monomers were synthe-
sized by Gardner et al. and studied as possible macromolecular 
cross-linkers.[16] Their hydrolysis half-life depended on the one 
hand strongly on the used VDMA content of the polymer, in gen-
eral solubility decreased with increasing VDMA content, and on 
the other hand also on the used co-monomer. Post-polymeriza-
tion functionalization with VDMA was so far, to our knowledge, 
only performed by Ho et al.[20] at the ω-position of a poly(N-iso-
propylacrylamide) (PNIPAM), obtained by RAFT polymerization, 
using thiol–ene Michael addition with dimethylphenylphosphine 
as catalyst in tetrahydrofuran. However, it can be anticipated that 
post-polymerization functionalization with VDMA on a polymer 
with multiple thiol groups at the side chain might be difficult due 
to the reactivity of azlactone toward nucleophiles.
The aim of this work was to make the azlactone function-
ality accessible to water-soluble POX polymers through post-
polymerization functionalization without the risk of any side 
reactions, which would allow selective and facile bioconjugation 
with this new class of biocompatible polymers.
2. Results and Discussion
Preliminary experiments, data not shown, revealed that the 
immediate attachment of vinyl dimethylazlactone at multi thiol-
functional POX copolymers through radical mediated as well as 
Michael addition-based thiol–ene reaction led to cross-linking 
of the individual dissolved polymer chains, which was to be 
expected since attached azlactone rings can be easily opened 
by remaining thiols of the polymer side chains. Hence, a new 
mercaptoacyl amino acid, N-(3-mercapto-1-oxopropyl)-2-methyl-
alanine (MOMA), based on the non-proteinogenic amino acid 
2-aminoisobutyric acid was synthesized adapted from Condon 
et al.[24] to overcome this problem. The synthesis is a two-
step approach, in the first step, the amine group of the amino 
acid is transformed into an amide by addition of 3-bromopro-
pionyl chloride and a thioester is introduced through the addi-
tion of thiobenzoic acid in a slightly alkaline environment. In 
the second step, the thioester is deprotected using ammonia, 
resulting in the mercaptoacyl amino acid MOMA. The thiol 
group of MOMA can subsequently be used for thiol–ene reaction 
with vinyl functionalities at POX side chains. For this purpose, 
poly(2-ethyl-2-oxazoline-co-2-butenyl-2-oxazoline) (P(EtOx-co- 
ButEnOx)) was synthesized by cationic ring opening polymeriza-
tion in a microwave reactor according to literature.[25] The theo-
retical chain length, which was set by the initiator to monomer 
ratio, matched with the experimental chain length as determined 
by 1H NMR end group analysis. Size exclusion chromatography 
(SEC) revealed a monomodal polymer with a dispersity of 1.14 
(Figure S7, Supporting Information). The functionalization of 
the copolymer P(EtOx-co-ButEnOx) with MOMA (Scheme 1A) 
was carried out in methanol with a photo-initiator at a wave-
length of 365 nm. 1H NMR analysis revealed that all vinyl groups 
of the copolymer had reacted and only a small excess of the 
thiol compound MOMA had to be used (Figure S6, Supporting 
Information). The IR spectrum of the functionalized copolymer 
revealed the stretching vibration of the carboxylic acid (CO) at 
1730 cm−1 and the bending vibration of the secondary amide 
(NH) at 1540 cm−1 of the attached MOMA, in addition to the 
carbonyl vibration of the numerous amides of the polymer back-
bone at 1633 cm−1 (Figure 1). The ring closure was efficiently 
performed in situ at the side chain using ethyl chloroformate 
and triethylamine (Scheme 1B). The successful formation of the 
azlactone ring could be observed by 1H NMR analysis (absence 
of secondary amide proton at 8.0 ppm) (Figure S6, Supporting 
Information) and by IR spectroscopy where the vibration of the 
carboxylic acid and the secondary amide of MOMA had disap-
peared and a new peak at 1815 cm−1 for the carbonyl group of 
the azlactone ring appeared (Figure 1). The SEC revealed that the 
modified polymer was still monomodal after the functionaliza-
tion and no observable side reaction had occurred, which fulfilled 
our aim to functionalize polymers at the side chain without any 
undesirable cross-linking (Figure S8, Supporting Information).
It is known from literature that the azlactone ring can react 
with amine, thiol, and hydroxyl groups but can also undergo 
a reaction with cysteine that is similar to that of the native 
chemical ligation[23,26] (Scheme 2A). The advantage of using a 
cysteine terminated peptide for the peptide–polymer conjuga-
tion is on the one hand that is was shown that these are more 
efficiently bound than primary amines[23] and on the other 
hand, after rearrangement, a free thiol is still available for fur-
ther reactions at the linkage site, which could, for example, be 
used for subsequent thiol–ene reactions to form chemically 
cross-linked hydrogels.
To test the azlactone functionality at the side chain, we 
chose two small molecules, cysteamine and cysteine methyl 
ester (CME) and a model peptide with the sequence CGGGF 
bearing an N-terminal cysteine and an aromatic amino acid, 
which would be visible in the 1H NMR spectroscopy and 
HPLC analysis (Scheme 2B). The reaction was carried out 
in dry DMSO as the azlactone ring is easily opened by water 
molecules and as catalyst triethylamine was added following 
the protocol of Ho et al.[20] After the reaction, the modified 
polymer was dialyzed for three days against water to make 
sure that any non-bound reaction partners were removed. The 
1H NMR spectrum of the freeze-dried sample of P(EtOx-co-
ButOxAL)-Cysteamine showed a new singlet in the region for 
amine groups at 7.59 ppm with a relative integral of 5, which 
would account for a functionalization of 91% (Figure 2A). As it 
is also possible that the thiol initially reacted with the azlactone 
group, the missing 9% might have reacted with the thiol end 
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of the cysteamine molecule. However, since the thioester is 
not stable and can be easily hydrolyzed as shown by Schmitt 
et al.,[23] it is possible that the thioesters were cleaved during 
dialysis and only the stable amide remained conjugated to the 
polymer chain. This experiment also shows that the amine 
group seems to be more reactive under the conditions tested. 
In addition, the carbonyl ring vibration at 1815 cm−1 in the IR 
spectrum of P(EtOx-co-ButOxAL)-Cysteamine completely disap-
peared again and a slightly larger peak of the vibration of the 
two secondary amide groups, which were introduced into the 
side chain by the attached cysteamine molecule, became visible 
(Figure S9A, Supporting Information). The successful reaction 
of P(EtOx-co-ButOxAL) with CME could also be detected with 
1H NMR spectroscopy with the appearance of an additional 
signal for the secondary amide group at 7.84–7.75 ppm and 
the additional alkyl signals of the CME molecule (Figure 2B). 
The integrals of the CME molecules that were attached to the 
polymer account for a functionalization degree of the available 
azlactone groups of approximately 90%, which is similar to the 
value obtained for cysteamine. The IR spectrum also shows the 
disappearance of the carbonyl ring vibration at 1815 cm−1 and a 
Macromol. Chem.  Phys. 2020, 221, 1900500
Scheme 1. Reaction scheme of the polymer analogue functionalization of side functional POx with azlactone. A) Thiol–ene reaction with azlactone 
precursor MOMA. B) Ring closure of azlactone at the side chain of POx.
Figure 1. Stacked IR spectra of the original polymer P(EtOx-co-
ButEnOx), the copolymer functionalized with the mercaptoacyl amino 
acid MOMA and the copolymer after ring closure showing specific car-
bonyl vibrations.
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new peak of the carboxylic ester of CME showing at 1740 cm−1 
in addition to the vibration of the secondary amide group at 
1540 cm−1 (Figure S9B, Supporting Information). The attach-
ment of the peptide CGGGF to the polymer side chain was also 
visible in the 1H NMR spectrum where the aromatic signals 
of the phenyl alanine amino acid showed at 7.22 ppm with an 
relative integral of 15.4, which would account for approximately 
three functionalized azlactone side chains (Figure 2C). The IR 
spectrum of the peptide functionalized polymer (Figure S9C, 
Supporting Information) shows the disappearance of the car-
bonyl ring vibration but also the appearance of the vibration 
of the carboxylic acid of the MOMA molecule, which can be 
explained by the fact that not all azlactone groups reacted with 
the peptide and were later opened by water molecules during 
dialysis. Nevertheless, there are also peaks visible originating 
from the attached peptide, for example, the valency vibration 
at 3280 cm−1 and the deformation vibration at 1525 cm−1 of the 
secondary amide groups. To further prove the attachment of 
the peptide, the compound was measured on a HPLC system. 
SEC did not prove applicable for analysis of the polymer pep-
tide conjugate as the peptide would strongly interact with the 
column material. The HPLC trace of the peptide, the original 
polymer P(EtOx-co-ButEnOx), as well as the azlactone function-
alized polymer and of the product of P(EtOx-co-ButOxAL) with 
CGGGF at the wavelength of 254 nm is shown in Figure S10, 
Supporting Information. Due to the aromatic ring of phenylala-
nine, the peptide appears as a strong signal at a retention time 
of 12.4 min. The unmodified polymer does not absorb light at 
this wavelength; hence it is barely visible. The azlactone func-
tionalized polymer shows a slight absorption. The trace of the 
polymer with the attached peptide does not show any signal at 
12.4 min, which confirms that the peptide signals that were vis-
ible in the NMR spectrum do not originate from the remaining 
free non-bound peptide. Instead, the signal intensity of the 
polymer–peptide conjugate has increased, confirming the suc-
cessful attachment of the peptide to the polymer.
In conclusion, the synthesis of the azlactone precursor 
MOMA, its facile attachment to vinyl functionalities and the ring 
closure in situ at very high yields, opens a new route to deco-
rate a large variety of vinyl functional polymers with azlactones. 
The azlactone functional polymers can further be used to subse-
quently attach different peptides, or even proteins, using orthog-
onal synthesis approach. This conjugation route is not solely 
limited to thiol-containing peptides, which can be attached to 
Macromol. Chem.  Phys. 2020, 221, 1900500
Scheme 2. A) Reaction of azlactone with cysteine function. Adapted with permission.[23] Copyright 2016, American Chemical Society. B) Reaction 
scheme of azlactone functionality with cysteine methyl ester, cysteamine, or model peptide CGGGF.
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polymers using thiol–ene chemistry,[27] but offers the flexibility 
to readily attach a variety of peptides via their amine functions.
3. Experimental Section
Materials and instruments used can be found in the Supporting 
Information.
Synthesis of MOMA: The synthesis of MOMA is a two-step synthesis 
adopted from Condon et al.[24] to produce mercaptoacyl amino acids. 
The first step is the synthesis of N-[3-(benzoylthio)-1-oxopropyl]-2-
methylalanine, which is deprotected in the second step to reveal the free 
thiol. 2-aminoisobutyric acid (6.0 g, 58 mmol, 1 equiv.) was dissolved in 
90 mL of 1.5 m NaOH in a round bottom flask with stirrer and cooled 
down in an ice bath. 3-bromopropionyl chloride (9.966 g, 58 mmol, 
1 equiv.) was added via syringe. The solution was left stirring for 0.5 h 
at room temperature and the pH was checked for neutrality. After slight 
adjustment with concentrated hydrochloric acid, the solution was further 
stirred for 3 h at room temperature. An aqueous solution of potassium 
carbonate (0.7 m) and thiobenzoic acid (8.837 g, 64 mmol, 1.1 equiv.) was 
added and the reaction mixture was stirred overnight. Concentrated HCl 
was added until the pH was acidic and a white solid was precipitated. 
Ethyl acetate (100 mL) was added in which the precipitate dissolved. The 
organic phase was then separated, and the solvent was removed under 
reduced pressure. N-[3-(benzoylthio)-1-oxopropyl]-2-methylalanine was 
received by crystallization from cold diethyl ether.
3 g (10.157 mmol) of N-[3-(benzoylthio)-1-oxopropyl]-2-methylalanine 
was diluted in 11 mL of water and 7.5 mL of concentrated ammonia 
was added. The suspension cleared momentarily with a white precipitate 
forming after a few minutes and the suspension was stirred for 2 h. 
10 mL of water was added and the white precipitate was filtered. The 
aqueous solution was washed three times with 15 mL of ethyl acetate. 
Concentrated HCl was added until the pH was acidic and the product as 
a white precipitate formed. The product was filtered out and freeze-dried 
to dryness.
Yield: 0.858 g, 4.486 mmol, 44.17%.
Macromol. Chem.  Phys. 2020, 221, 1900500
Figure 2. A) 1H NMR in DMSO-d6 of P(EtOx-co-ButOxAL) which has reacted with cysteamine with the secondary amide of the opened azlactone ring 
at 7.96 ppm and the secondary amide of the reacted cysteamine at 7.59 ppm. B) 1H NMR in DMSO-d6 of P(EtOx-co-ButOxAL) which has reacted with 
cysteine methyl ester with the secondary amide of the opened azlactone ring at 7.94 ppm and the secondary amide of the reacted cysteine methyl 
ester at 7.84 and 7.75 ppm (doublet). C) 1H NMR in DMSO-d6 of P(EtOx-co-ButOxAL) which has reacted with the peptide CGGGF (in gray) with the 
secondary amide of the opened azlactone ring at 8.13 ppm and the aromatic signals of the phenyl alanine amino acid at 7.22 ppm. The integral value 
of the aromatic signal indicates that 3 of the 5.5 possible side chains were functionalized with the peptide.
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1H NMR (300 MHz, DMSO-d6, ppm): δ = 12.11 (s, 1H, COOH), 8.09 
(s, 1H, NH), 2.62 (t, 2H, CH2), 2.37 (q, 2H, CH2), 2.22 (s, 1H, SH), 1.33 
(s, 6H, 2 × CH3).
13C NMR (300 MHz, DMSO-d6, ppm): δ = 174.37 (carboxylic 
acid CO), 168.57 (amide CO), 53.61 (COC(CH3)2NH), 38.66 
(COCH2CH2S, hidden by solvent peaks), 23.82 (C(CH3)2), 18.86 
(COCH2CH2S).
EI-MS m/z: [M + H]+ calculated for C7H13NO3S, 191.6; found, 191.0
IR spectrum (cm−1): ν = 3308 (amide, NH valency), 3247–2688 (CH2, 
CH3 valency), 1720 (CO valency), 1612 (NH deformation), 1545 (NH 
deformation), 1465–672 (CH2, CH3 deformation).
Raman spectrum (cm−1): ν = 3000–2870 (CH), 2572 (S-H), 773 
(C-Saliphatic).
Synthesis of P(EtOx-co-ButEnOx): The main monomer 2-ethyl-
2-oxazoline (EtOx) was distilled to dryness before use and the 
co-monomer 2-butenyl-2-oxazoline (ButEnOx) was prepared according 
to Gress et al.[28]
The random copolymer was prepared in a microwave reactor at 
100 °C for 2 h with the initiator methyl tosylate (MeTos) and the solvent 
acetonitrile following the protocol of Wiesbrock et al.[29] The initiator 
to monomer ratio determined the chain length and was set at 1:50:5 
(MeTos:EtOx:ButEnOx). The polymer was terminated using 3 equiv. of 
piperidine and received as a white powder after precipitation in cold 
diethyl ether from chloroform.
1H NMR of P(EtOx0.89-co-ButEnOx0.11)56 (300 MHz, CD3CN, ppm): 
δ = 7.61 (d, aromat., tosylate anion), 7.17 (d, aromat., tosylate anion), 
5.85 (m, 5.5H, CHCH2), 4.99 (m, 11H, CHCH2), 3.42 (m, 222H, 
NCH2CH2 backbone), 2.96 (d, 2H, CH3N), 2.86 (s, 1H, CH3N), 2.33 (m, 
133H, NCH2CH3, NCH2CH2CH2CH), 1.76–1.37 (m, 10H, N(CH2)5), 1.03 
(m, 150H, NCH2CH3).
SEC (DMF): Mn = 6577 g mol−1, Mw = 7471 g mol−1, Ð = 1.14, 
elugram can be found in the Supporting Information.
Functionalization of P(EtOx-co-ButEnOx): The copolymer P(EtOx0.89-co-
ButEnOx0.11)56 was dissolved in methanol and the solution was degassed 
with argon for 15 min. MOMA (1.5 equiv. per double bond function of 
the copolymer) and 0.5 equiv. of the photo-initiator 2,2-dimethoxy-2-
phenylacetophenone were added and the solution was stirred under UV 
light (λ = 365 nm) for 30 min. The solvent was removed under reduced 
pressure and the polymer was dialyzed against water for 1 d to remove 
excess MOMA. The polymer was received as a white powder after 
freeze-drying.
1H NMR of P(EtOx0.89-co-ButOxMOMA0.11)56 (300 MHz, DMSO-d6, 
ppm): δ = 8.03 (s, 5.7H, NH), 3.35 (m, 248H, NCH2CH2 backbone), 
2.96 (d, 2H, CH3N), 2.86 (s, 1H, CH3N), 2.61 (m, 14H, SCH2CH2CO), 
2.30 (m, 124H, CCH2CH3, CCH2CH2CH2CH), 1.52 (m, 27H, 
CCH2(CH2)2CH2S), 1.32 (s, 37H, C(CH3)2), 1.03 (m, 150H, CCH2CH3).
IR spectrum (cm−1): ν = 3040–2755 (CH2, CH3 valency), 1730 
(CO valency, carboxylic acid), 1633 (CO valency, amide), 1542 (NH 
deformation), 1507–990 (CH2, CH3 deformation).
The ring-closure at the side chain of P(EtOx0.89-co-ButOxMOMA0.11)56 
was performed similar to the synthesis of the monomer 2-vinyl-4,4-
dimethylazlactone[15] by dissolving the dry polymer in DMF and adding 
triethylamine (3 equiv. per MOMA function at the side chain). After 
cooling the reaction mixture to 0 °C, ethyl chloroformate (2 equiv. per 
MOMA functionality) was added dropwise and the reaction mixture 
was stirred for 3 h at 0 °C. The white crystalline was removed by 
centrifugation and the solvent was removed under reduced pressure. 
The polymer was precipitated three times from dry dichloromethane 
in cold diethyl ether. The residual solvent was removed under reduced 
pressure and the polymer was received as a slightly yellowish powder 
and stored under inert atmosphere.
1H NMR of P(EtOx0.89-co-ButOxAL0.11)56 (300 MHz, DMSO-d6, ppm): 
δ = 3.35 (m, 247H, NCH2CH2 backbone), 2.96 (d, 2H, CH3N), 2.86 (s, 
1H, CH3N), 2.75 (m, 23H, SCH2CH2C), 2.55 (m, 11H, CCH2(CH2)2CH2S), 
2.29 (m, 110H, CCH2CH3, CCH2(CH2)2CH2S), 1.52 (m, 22H, 
CCH2(CH2)2CH2S), 1.31 (s, 37H, C(CH3)2), 1.03 (m, 150H, CCH2CH3).
SEC (DMF): Mn = 6987 g mol−1, Mw = 7776 g mol−1, Ð = 1.11, 
elugram can be found in the Supporting Information.
IR spectrum (cm−1): ν = 3040–2755 (CH2, CH3 valency), 1815 (CO 
valency, azlactone carbonyl), 1633 (CO valency, amide), 1507–990 
(CH2, CH3 deformation).
Conjugation Reactions to Azlactone Functional POx Copolymer: 0.100 g 
of P(EtOx0.89-co-ButOxAL0.11)56 was dissolved in 4 mL of dry DMSO 
and degassed with argon for 15 min. 3 equiv. (for every azlactone 
functionality) of cysteamine, cysteine methyl ester or the peptide 
CGGGF was added. As base, 10 equiv. of triethylamine was added, and 
the solution was stirred for 12 h under inert atmosphere. The product 
was dialyzed against acidified water (pH 3) for 3 days and received as a 
white powder after lyophilization.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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